These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 178277)

  • 21. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of estrogen receptor in breast cancer.
    Singhakowinta A; Saunders DE; Brooks SC; Samal B; Vaitkevicius VK
    Cancer; 1980 Dec; 46(12 Suppl):2932-8. PubMed ID: 7448740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients.
    Nomura Y; Yamagata J; Kondo H
    Gan; 1979 Aug; 70(4):473-82. PubMed ID: 510847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endocrine therapy of recurrent breast cancer].
    Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor: a valid test for selection of breast cancer patients for endocrine ablation.
    Leung BS; Fletcher WS; Krippaehne WW
    Surg Forum; 1973; 24():125-7. PubMed ID: 4142813
    [No Abstract]   [Full Text] [Related]  

  • 27. [Endocrine-surgical treatment of skeletal metastases].
    Dagradi A; Petronio R
    Clin Ortop; 1972; 23(1):1-25. PubMed ID: 5084890
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogen receptor in breast cancer of the Japanese.
    Nomura Y
    Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: L-dopa effect in painful bony metastases.
    Minton JP; Bronn DG; Kibbey WE
    N Engl J Med; 1976 Feb; 294(6):340. PubMed ID: 813142
    [No Abstract]   [Full Text] [Related]  

  • 31. Prediction of breast cancer response to endocrine therapy.
    DeSombre ER; Smith S; Block GE; Ferguson DJ; Jensen EV
    Cancer Chemother Rep; 1974; 58(4):513-9. PubMed ID: 4369030
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
    Maass H; Jonat W
    Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test].
    Cueto Ladrón de Guevara J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):459-70. PubMed ID: 3870537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
    Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
    J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenalectomy for disseminated breast cancer.
    Garas J; Stravolemos K; Athanasiou E; Fassoulaki A
    Int Surg; 1979; 64(6):55-7. PubMed ID: 263073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].
    Bocci A; Campagnoli C
    Minerva Chir; 1976 Nov; 31(22):1371-6. PubMed ID: 1012556
    [No Abstract]   [Full Text] [Related]  

  • 38. Letter: Use of L-dopa to relieve pain from bone metastases.
    Nixon DW
    N Engl J Med; 1975 Mar; 292(12):647. PubMed ID: 1113750
    [No Abstract]   [Full Text] [Related]  

  • 39. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients.
    Nomura Y; Kobayashi S; Takatani O; Sugano H; Matsumoto K; McGuire WL
    Cancer Res; 1977 Jan; 37(1):106-10. PubMed ID: 830399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study.
    Engelsman E; Heuson JC; Blonk Van Der Wijst J; Drochmans A; Maass H; Cheix F; Sobrinho LG; Nowakowski H
    Br Med J; 1975 Jun; 2(5973):714-5. PubMed ID: 1095122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.